MONITORING DRUG THERAPY IN X’s PHARMACY IN BADUNG REGENCY

  • Pratiwi Diva Yanti Luh Department of Pharmacy, Faculty of Math and Science, Udayana University
  • I M.A.G. Wirasuta Department of Pharmacy, Faculty of Math and Science, Udayana University
  • Luh Rai Maduretno Asvinigita Department of Pharmacy, Faculty of Math and Science, Udayana University
DOI: https://doi.org/10.24843/JPSA.2021.v03.i01.p03

Abstract

Background: Monitoring drug therapy based on Permenkes RI No. 73 of 2016 is one of the pharmaceutical care standards in pharmacy practice. Monitoring drug therapy is a process that includes activities to ensure safe, effective and rational drug therapy for patients. Patients who receive drug therapy are at risk of experiencing drug-related problems. Objective: This study aims to determine the implementation of monitoring drug therapy in one pharmacy in Badung Regency. Methods: The type of research is a descriptive observational study conducted by interview session one pharmacist in X Pharmacy, then analyzed descriptively according to Permenkes RI No 73 of 2016. Results: The results showed that in January-June 2020 there were 34 patients with disease categories requiring monitoring drug therapy: 27 patients with asthma (79%), six patients with diabetes (18%), and one patient with tuberculosis (3%). Patients with the largest visits were geriatric, which were 19 out of 34 patients. Conclusion: The monitoring of drug therapy at Pharmacy X has fulfilled all the parameters in the Standard Operating Procedure (SOP) for the implementation of in Pharmacy based on Permenkes RI No.73 of 2016.
Keywords: Monitoring drug therapy, Implementation, Pharmacy, Pharmacist

Downloads

Download data is not yet available.
Published
2021-06-01
How to Cite
YANTI LUH, Pratiwi Diva; WIRASUTA, I M.A.G.; ASVINIGITA, Luh Rai Maduretno. MONITORING DRUG THERAPY IN X’s PHARMACY IN BADUNG REGENCY. Journal Pharmaceutical Science and Application, [S.l.], v. 3, n. 1, p. 25-31, june 2021. ISSN 2301-7708. Available at: <https://ojs.unud.ac.id/index.php/jpsa/article/view/62380>. Date accessed: 22 nov. 2024. doi: https://doi.org/10.24843/JPSA.2021.v03.i01.p03.
Citation Formats
Issue
Vol 3 No 1 (2021): Journal Pharmaceutical Science and Application
Section
Articles
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.

Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.

Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work. (See The Effect of Open Access).

 

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.